Headquartered in California, Amgen (Applied Molecular Genetics) is an Multinational Biopharmaceutical company which was known as Applied Molecular Genetics. Founded in 1980 It is the world’s largest independent biotechnology firm. Amgen (Applied Molecular Genetics) leverages its biologic manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives.
The company is focused on diseases like cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses and has presences in over 75 countries. Company’s largest selling product lines Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. These medicines have helped over 1 million people in their fight against cancer.
|Traded as||NASDAQ: AMGN|
|Headquarters||Thousand Oaks, California, U.S.|
|Key people||Robert A. Bradway (President and CEO)|
|Products||Epogen, Aranesp, Kineret, Enbrel, Neulasta, Neupogen, Nplate, Vectibix, Prolia, Xgeva and Sensipar/Mimpara|
|Revenue||US$ 20.063 billion (2014)|
|Net income||US$ 5.158 billion (2014)|
|Number of employees||17,900 (December 2014)|